Small testicular volume and elevated FSH in an adolescent with a maternally inherited 12p13.32 deletion encompassing CCND2

Background Proximal loss-of-function variants in Cyclin D2 (CCND2) cause a recognized syndrome of microcephaly, short stature, and developmental delay. Animal models establish an additional role for CCND2 in follicle-stimulating hormone (FSH)-driven gonadal cell proliferation. Human gonadal dysfunction associated with CCND2 haploinsufficiency has not previously been reported. Methods We performed detailed clinical, auxological, and endocrine phenotyping of an affected mother-son pair, followed by chromosomal microarray analysis and whole-exome sequencing to characterize the underlying genetic variant. Results A 15-year-old male and his mother were found to carry a heterozygous 1.74 Mb deletion at 12p13.32 encompassing CCND2. The proband presented with microcephaly (−4.8 standard deviation scores [SDS]), symmetric short stature (−2.8 SDS), and developmental delay. Physical examination revealed bilateral small testes (under 4 mL). Ultrasonography demonstrated testicular volumes of 3.1 mL (right) and 6.3 mL (left); after conversion to the reference formula, these corresponded to SDS of −3.0 and −1.9, respectively. Serial gonadal axis evaluation before aromatase inhibitor treatment showed a progressive rise in FSH (from 7.8 to 13.0 IU/L), with normal luteinizing hormone (LH) and testosterone levels. Together with progression of pubic hair development to Tanner stage P4–P5, this pattern suggests Sertoli cell dysfunction with preserved Leydig cell function. The mother, who carries the same deletion, had seven spontaneous pregnancies without fertility intervention. Conclusion These findings represent, to our knowledge, the first report of small testicular volume with elevated FSH in an individual with a deletion encompassing CCND2, suggesting that the phenotypic spectrum of CCND2-related disorder may extend to Sertoli cell dysfunction. Gonadal axis evaluation may warrant consideration in the clinical assessment of individuals with CCND2 loss-of-function variants or deletions encompassing CCND2.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-11-12
DOI
https://doi.org/10.3389/fendo.2026.1964726
Primary Topic
Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Small testicular volume and elevated FSH in an adolescent with a maternally inherited 12p13.32 deletion encompassing CCND2

David Shaki, Ginat Narkis, Lior Carmon, Eli Hershkovitz et al.
Frontiers in Endocrinology
Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
article

Small testicular volume and elevated FSH in an adolescent with a maternally inherited 12p13.32 deletion encompassing CCND2

David Shaki, Ginat Narkis, Lior Carmon, Eli Hershkovitz, Majd Nassar, Alon Haim, Gil Smooha-Schechter, Neta Loewenthal
article en

Abstract

Background Proximal loss-of-function variants in Cyclin D2 (CCND2) cause a recognized syndrome of microcephaly, short stature, and developmental delay. Animal models establish an additional role for CCND2 in follicle-stimulating hormone (FSH)-driven gonadal cell proliferation. Human gonadal dysfunction associated with CCND2 haploinsufficiency has not previously been reported. Methods We performed detailed clinical, auxological, and endocrine phenotyping of an affected mother-son pair, followed by chromosomal microarray analysis and whole-exome sequencing to characterize the underlying genetic variant. Results A 15-year-old male and his mother were found to carry a heterozygous 1.74 Mb deletion at 12p13.32 encompassing CCND2. The proband presented with microcephaly (−4.8 standard deviation scores [SDS]), symmetric short stature (−2.8 SDS), and developmental delay. Physical examination revealed bilateral small testes (under 4 mL). Ultrasonography demonstrated testicular volumes of 3.1 mL (right) and 6.3 mL (left); after conversion to the reference formula, these corresponded to SDS of −3.0 and −1.9, respectively. Serial gonadal axis evaluation before aromatase inhibitor treatment showed a progressive rise in FSH (from 7.8 to 13.0 IU/L), with normal luteinizing hormone (LH) and testosterone levels. Together with progression of pubic hair development to Tanner stage P4–P5, this pattern suggests Sertoli cell dysfunction with preserved Leydig cell function. The mother, who carries the same deletion, had seven spontaneous pregnancies without fertility intervention. Conclusion These findings represent, to our knowledge, the first report of small testicular volume with elevated FSH in an individual with a deletion encompassing CCND2, suggesting that the phenotypic spectrum of CCND2-related disorder may extend to Sertoli cell dysfunction. Gonadal axis evaluation may warrant consideration in the clinical assessment of individuals with CCND2 loss-of-function variants or deletions encompassing CCND2.

Frontiers in EndocrinologyVol. 17
Ben-Gurion University of the Negev (IL), Soroka Medical Center (IL)
Good health and well-being
Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon